Correlation Between 23Andme Holding and Xeris Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both 23Andme Holding and Xeris Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 23Andme Holding and Xeris Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 23Andme Holding Co and Xeris Pharmaceuticals, you can compare the effects of market volatilities on 23Andme Holding and Xeris Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 23Andme Holding with a short position of Xeris Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of 23Andme Holding and Xeris Pharmaceuticals.
Diversification Opportunities for 23Andme Holding and Xeris Pharmaceuticals
-0.59 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between 23Andme and Xeris is -0.59. Overlapping area represents the amount of risk that can be diversified away by holding 23Andme Holding Co and Xeris Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Xeris Pharmaceuticals and 23Andme Holding is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 23Andme Holding Co are associated (or correlated) with Xeris Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Xeris Pharmaceuticals has no effect on the direction of 23Andme Holding i.e., 23Andme Holding and Xeris Pharmaceuticals go up and down completely randomly.
Pair Corralation between 23Andme Holding and Xeris Pharmaceuticals
Allowing for the 90-day total investment horizon 23Andme Holding Co is expected to under-perform the Xeris Pharmaceuticals. In addition to that, 23Andme Holding is 2.56 times more volatile than Xeris Pharmaceuticals. It trades about -0.22 of its total potential returns per unit of risk. Xeris Pharmaceuticals is currently generating about 0.11 per unit of volatility. If you would invest 323.00 in Xeris Pharmaceuticals on August 30, 2024 and sell it today you would earn a total of 22.00 from holding Xeris Pharmaceuticals or generate 6.81% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
23Andme Holding Co vs. Xeris Pharmaceuticals
Performance |
| Timeline |
| 23Andme Holding |
| Xeris Pharmaceuticals |
23Andme Holding and Xeris Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with 23Andme Holding and Xeris Pharmaceuticals
The main advantage of trading using opposite 23Andme Holding and Xeris Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 23Andme Holding position performs unexpectedly, Xeris Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Xeris Pharmaceuticals will offset losses from the drop in Xeris Pharmaceuticals' long position.| 23Andme Holding vs. IDEXX Laboratories | 23Andme Holding vs. Twist Bioscience Corp | 23Andme Holding vs. Guardant Health | 23Andme Holding vs. Agilent Technologies |
| Xeris Pharmaceuticals vs. Protalix Biotherapeutics | Xeris Pharmaceuticals vs. Seres Therapeutics | Xeris Pharmaceuticals vs. Cidara Therapeutics | Xeris Pharmaceuticals vs. Immunitybio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |